uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Is pathologic complete response (pCR) a valid marker of outcome even in large breast cancer?: Clinical results from a neoadjuvant trial using a combination of epirubicin, docetaxel and bevacizumab (PROMIX)
Show others and affiliations
2015 (English)In: Cancer Research, ISSN 0008-5472, E-ISSN 1538-7445, Vol. 75, no 9, P3-11-14Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2015. Vol. 75, no 9, P3-11-14
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-259213ISI: 000356730202108OAI: oai:DiVA.org:uu-259213DiVA: diva2:843706
37th Annual CTRC-AACR San Antonio Breast Cancer Symposium, DEC 09-13, 2014, San Antonio, TX
Available from: 2015-07-30 Created: 2015-07-29 Last updated: 2015-07-30Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Lindman, Henrik
By organisation
Experimental and Clinical Oncology
In the same journal
Cancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 156 hits
ReferencesLink to record
Permanent link

Direct link